Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Gentofte Hospital
Sponsor

Gentofte Hospital

Denmark Gentofte Hospitalsvej 1, 2900 Hellerup, Denmark

About the sponsor

Research activity includes influenza, RSV infection, SARS-CoV-2 infection, and herpes zoster, with attention to prevention of severe respiratory outcomes and vaccine-related immune responses in older adults.

  • Influenza vaccination
  • COVID-19 prevention
  • RSV-related respiratory disease
  • Herpes zoster vaccination

Studies also examine mucosal immunity and innate immune training after live or intranasal vaccination strategies.

About Specializations

Gentofte Hospital runs clinical trials in conditions such as Influenza, Type 1 diabetes mellitus, Hidradenitis, Pneumonia, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

24 clinical trials

Herpes zoster

Recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:65+ years · Healthy volunteers
  • Substances:Recombinant Varicella Zoster Virus Glycoprotein E
  • Sponsor:Gentofte Hospital

Hypersensitivity+1

Recruiting
InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin Trihydrate
  • Sponsor:Austin Health

Type 1 diabetes mellitus

Recruiting
Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Gentofte Hospital

Hidradenitis

Recruiting
Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Frederiksberg Hospital

Pneumonia

Recruiting
Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Levofloxacin
  • Sponsor:Gentofte Hospital

Atrial fibrillation

Recruiting
Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Autumn Crocus Fresh Flower Fluid Extract (1:15-25), Extraction Solvent Ethanol 96% (V/V)
  • Sponsor:Gentofte Hospital

Hidradenitis

Not yet recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Adalimumab
  • Sponsor:Gentofte Hospital

COVID-19+1

Not yet recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:65+ years · Healthy volunteers
  • Substances:B/Phuket/3073/2013-Like Virus (B/Phuket/3073/2013, Wild Type)
  • Sponsor:Gentofte Hospital

Obesity

Not yet recruiting
Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Orismilast
  • Sponsor:Gentofte Hospital

Pneumonia

Not yet recruiting
Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Levofloxacin
  • Sponsor:Gentofte Hospital

Chronic kidney disease

Not yet recruiting
Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin Propanediol
  • Sponsor:Gentofte Hospital

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

ClinicalTrials.eu

Every clinical trial in Europe, in plain language.

Explore the full ecosystem of clinical research in Europe.

Search trials

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).